These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9458851)

  • 21. Hyporesponsiveness to Ca2+ of aortic smooth muscle in endotoxin-treated rats: no-dependent and -independent in vitro mechanisms.
    Ho KH; Kwan CY; Bourreau JP
    Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):275-84. PubMed ID: 8827826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats.
    de Campos Grifoni S; Bendhack LM
    Pharmacology; 2004 Mar; 70(3):160-8. PubMed ID: 14752236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform.
    Garcia-Cohen EC; Marin J; Diez-Picazo LD; Baena AB; Salaices M; Rodriguez-Martinez MA
    J Pharmacol Exp Ther; 2000 Apr; 293(1):75-81. PubMed ID: 10734155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production.
    Gerová M; Török J; Pecháòová O; Matusková J
    Acta Pharmacol Sin; 2004 Dec; 25(12):1640-6. PubMed ID: 15569409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase.
    Haefliger JA; Meda P; Formenton A; Wiesel P; Zanchi A; Brunner HR; Nicod P; Hayoz D
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1615-22. PubMed ID: 10397678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbon monoxide does not contribute to vascular tonus improvement in exercise-trained rats with chronic nitric oxide synthase inhibition.
    Ülker SN; Koçer G; Şentürk ÜK
    Nitric Oxide; 2017 May; 65():60-67. PubMed ID: 28257997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effects of 7-nitroindazole and L-NAME administered both individually and together on the cardiovascular system of the rat.
    Kristek F; Drobna M; Cacanyiova S
    Physiol Res; 2015; 64(1):1-10. PubMed ID: 25194127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.
    Bartunek J; Weinberg EO; Tajima M; Rohrbach S; Katz SE; Douglas PS; Lorell BH
    Circulation; 2000 Feb; 101(4):423-9. PubMed ID: 10653835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
    Hsu YH; Hsu BG; Chen HI
    Chin J Physiol; 2007 Dec; 50(6):283-93. PubMed ID: 18442011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
    Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nitric oxide synthase inhibitor on tyrosine hydroxylase mRNA in the adrenal medulla of spontaneously hypertensive and Wistar Kyoto rats.
    Kumai T; Asoh K; Tateishi T; Tanaka M; Watanabe M; Kobayashi S
    Nitric Oxide; 1999 Aug; 3(4):321-6. PubMed ID: 10444371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings.
    Zhang C; Wang XH; Zhong MF; Liu RH; Li HL; Zhang WD; Chen H
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):387-92. PubMed ID: 17439405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
    J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D; Zhao YY; Kelso EJ; McHenry EM; Rush LM; Lamont VM; Nicholls DP; McDermott BJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.